Business Wire

TOFANE-GLOBAL

9.1.2023 18:01:40 CET | Business Wire | Press release

Share
Tofane Global Acquires DIMOCO Messaging to Boost iBASIS Mobile Services

Tofane Global (TOFANE), the leading international communications solutions group, announces today the acquisition of DIMOCO Messaging, a leading global SMS aggregator based in Liechtenstein and Austria that delivers around two billion messages per year.

Business messaging or application-to-person (A2P) has grown into a global market worth an estimated 26.5 billion USD in 2022 and is predicted to reach 38 billion USD in 2025. With only 5% of companies using SMS A2P, business adoption of messaging is still in its infancy but is starting to surge as organizations come to realize that business SMS can become a key revenue generator for mobile operators.**

With this acquisition, TOFANE’s subsidiary iBASIS significantly accelerates its growth, doubling mobile services revenues to reach 20% of the company’s total revenues.

The addition of DIMOCO Messaging enhances iBASIS’s carrier-grade network infrastructure by adding more than 100 direct connections to mobile operators worldwide, ensuring the highest standards of speed and reliability for message termination.

iBASIS geographically expands its global commercial presence with DIMOCO Messaging’s offices located in Liechtenstein, Austria, Germany, and Serbia.

The acquisition also gives direct access to the enterprise market segment where DIMOCO Messaging has an established sales force to serve large financial institutions, leveraging new SMS Application Program Interfaces for system integration, APIs for rapid onboarding, and SMS campaign deployment.

Alexandre Pébereau, CEO, iBASIS, and Founder, CEO, TOFANE:

“TOFANE established itself as the first independent leader through acquisitions in international voice. Today, we are replicating our model in the similar but high-growth Business Messaging sector to build our second pillar. By adding DIMOCO Messaging and its senior team, we are boosting our growth path to become the preferred Tier One partner for our customers in mobile services.”

Cameron Calof, Managing Director, DIMOCO Messaging:

“We are very excited to join iBASIS. The company has built a Tier One reputation as preferred partner for global voice and mobile services. We share the same entrepreneurial spirit, business ethics, and customer-centric approach, and are committed to delivering a high level of quality and reliability for messaging worldwide. We are thrilled for our employees and customers as this acquisition opens a new era of possibilities and growth. iBASIS’ expertise and capabilities are undisputed, and we look forward to continuing to respond to the industry’s fast-growing market requirements together.”

Jeantet acted as exclusive legal adviser, Mazars as finance and tax adviser, Wagram Corporate Finance as financial adviser, and Global Telco Consult – GTC as technical adviser on this acquisition.

* DACH: Deutschland (D), Austria (A), and Switzerland (CH)
** Mobilesquared, Business Messaging Overview at MEF Business Messaging, June 2022

About Tofane Global

Tofane Global (TOFANE) is the leading communications solutions group enabling operators and digital players worldwide with their core strategies, performance, and transformation. Tofane Global acquired and successfully integrated seven companies in the global communications market, becoming the first independent player and innovation enabler across international Voice, Mobile Data and SMS messaging, Internet-of-Things, and 5G. As the result of the acquisitions of Altice Europe N.V., iBASIS, SFR, MEO (former Portugal Telecom), NOS, and Simfony, Tofane Global serves 1,000+ customers worldwide across its presence in 26 countries.

About DIMOCO Messaging

Before its acquisition by Tofane Global, DIMOCO Messaging was owned by BaseTech Ventures, an investment venture that invests in early-stage FinTech, internet, and technology start-ups. DIMOCO Messaging provides high quality, reliable A2P messaging products enabling our enterprise clients to communicate to their customers on a truly global scale. We leverage our relationships with Mobile Network Operators, CPaaS and in-country partners to offer clients direct connectivity, allowing them to optimize communication with their customers and employees seamlessly. DIMOCO Messaging, with offices in Liechtenstein, Austria, Germany, and Serbia, holds an MVNO license and operates a carrier-grade messaging platform with highest quality industry standards.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005012/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

Seoul Viosys Eyes the $60 Billion AI Data Center Optical Communication Market with Opto Semiconductors27.4.2026 15:00:00 CEST | Press release

Joint Development Talks with Global Optical Communications companiesExpanding Partnerships to Provide Total Transceiver Solution1,800 Patents Secured for High-Performance Optical Communications Seoul Viosys (KOSDAQ: 092190), a company specializing in opto-semiconductor devices, is accelerating its entry into the next-generation photonics market supported by its proprietary “No-wire” and “No-package” fundamental patents—essential technologies for micrometer (μm)-scale miniaturization of opto-semiconductors—as well as its competitiveness in VCSEL technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426926495/en/ Seoul Viosys Optoelectronic Semiconductor Structure Subject to a Permanent U.S. Injunction in February 2026, Covering Similar Products and Employees (Image: Seoul Viosys) As the rapid expansion of AI drives a paradigm shift in data centers from copper-based to optical-based architectures, the company is streng

vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 14:51:00 CEST | Press release

Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye